Natural Derivatives of Selective HDAC8 Inhibitors with Potent in Vivo Antitumor Efficacy against Breast Cancer DOI
Xiaohong Chen,

Xia Ding,

Jiebin Fang

et al.

Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 67(16), P. 14609 - 14632

Published: Aug. 7, 2024

HDAC8 is a therapeutic target with great promise for breast cancer. Here, we reported novel compound corallorazine D from

Language: Английский

Mechanism of action and treatment of type I interferon in hepatocellular carcinoma DOI

Chunxiu Peng,

Zhijian Ye,

Ying Ju

et al.

Clinical & Translational Oncology, Journal Year: 2023, Volume and Issue: 26(2), P. 326 - 337

Published: July 4, 2023

Language: Английский

Citations

7
Natural Derivatives of Selective HDAC8 Inhibitors with Potent in Vivo Antitumor Efficacy against Breast Cancer DOI
Xiaohong Chen,

Xia Ding,

Jiebin Fang

et al.

Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 67(16), P. 14609 - 14632

Published: Aug. 7, 2024

HDAC8 is a therapeutic target with great promise for breast cancer. Here, we reported novel compound corallorazine D from

Language: Английский

Citations

1